High - Yielding Dividend Stocks

Search documents
Create a Portfolio of Passive Income: 3 High-Yielding Dividend Stocks That Pay More Than 5%
The Motley Fool· 2025-06-12 09:00
Core Viewpoint - Dividend income is a valuable strategy for enhancing financial stability and potentially reducing dependence on employment income, which can lead to a more fulfilling life [1] Group 1: High-Yielding Dividend Stocks - Pfizer is highlighted as a long-term investment option with a current yield of 7.4%, significantly higher than the S&P 500 average of 1.3% [4] - Despite a decline of over 10% in stock price this year, Pfizer's valuation remains modest at 17 times trailing earnings, with revenue guidance between $61 billion and $64 billion for the year [5][6] - Realty Income is a recommended REIT with a high yield of 5.8% and monthly dividend payments, providing a consistent cash flow for investors [8] - Realty Income reported funds from operations (FFO) per share of $1.05, up from $0.94 a year ago, supporting its dividend payout [9][10] - Bank of Nova Scotia offers a high dividend yield of around 6%, with a strong historical track record of regular payments since 1833 [11] - The bank's net income was over 2 billion Canadian dollars for the quarter ending April 30, showing stability despite macroeconomic concerns [12] - Scotiabank has increased its dividend by more than 22% over the past four years, making it a solid long-term investment option [13]
The Smartest High-Yielding Dividend Stocks in the Nasdaq Composite Index to Buy With $1,500 Right Now
The Motley Fool· 2025-05-24 11:15
Market Overview - The stock market is experiencing volatility, with the S&P 500 index falling nearly 20% from February highs but recovering fully by May 22 [1] - Investors are concerned about high tariffs, a proposed major tax bill, and the potential for recession or rising inflation [1] Amgen - Amgen is a pharmaceutical company known for its diverse range of drugs, including Enbrel, Prolia, XGEVA, Otezla, and Repatha [3] - The company is developing a weight-loss drug, MariTide, and has initiated two phase 3 trials [4] - In Q1, Amgen reported adjusted earnings of $4.90 per share, surpassing Wall Street estimates of $4.26, with revenue growth of 9% year over year [6] - Amgen has consistently paid dividends since 2011, increasing them for 14 consecutive years, with a current dividend yield of approximately 3.5% [7] - Management expects free cash flow to rebound to $7.4 billion in 2023, covering the expected $5.2 billion in dividend payments [7] Sirius XM - Sirius XM is a leading digital audio company in the U.S., operating Sirius satellite radio and Pandora, reaching 160 million listeners monthly [8] - The company has faced significant challenges, with stock down about 57% over the last five years due to rising competition and declining subscribers [8] - Management is investing in technology, expanding its podcast network, and streamlining subscription offerings, aiming for a 25% increase in subscribers to 50 million and a 50% increase in free cash flow to $1.8 billion [9] - In Q1, Sirius XM's revenue fell 4.3% year over year, and total U.S. subscribers declined by 2% [10] - The company offers a 4.9% dividend yield, having regularly paid and increased its annual dividend since 2017, with a trailing free cash flow yield close to 10% [11]